IP Verse

Generics Uk competitive analysis

Loading summary...

Explore patent oppositions filed by Generics Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 6, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3539540	Pharmaceutical Composition, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Sep 18, 2025
EP4188389	Methods Of Treating Chronic Kidney Disease With Dapagliflozin	ASTRAZENECA	Sep 17, 2025
EP3875105	Method For Preventing Or Treating Osteoporosis Characterized By Administering Teriparatide Or Salt Thereof Twice A Week	ASAHI KASEI PHARMA	Aug 27, 2025
EP3689365	Use Of Long-Acting Glp-1 Peptides	NOVO NORDISK	Aug 7, 2025
EP4070800	Cladribine Regimen For Treating Multiple Sclerosis	MERCK SERONO	Jul 16, 2025
EP4125903	Methods For Dose Initiation Of Aripiprazole Treatments	OTSUKA PHARMACEUTICAL	Jul 9, 2025
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 1, 2025
EP3897582	Process Of Spray Drying Of Glp-1 Peptide	NOVO NORDISK	Jun 11, 2025
EP4065119	Methods Of Treating Pulmonary Arterial Hypertension	ACTELION PHARMACEUTICALS	Jun 4, 2025
EP3923943	Genotype And Dose-Dependent Response To An Asbti In Patients With Bile Salt Export Pump Deficiency	MIRUM PHARMACEUTICALS	Apr 30, 2025

Discover the latest PTAB cases involving Generics Uk, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Generics Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 6, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
GENERICS UK TRADING MYLAN	13	-	-	-
ALCON RESEARCH	-	14	1	8
NOVARTIS	6	422	-	21
YEDA RESEARCH	-	21	-	9